The report the global molecular diagnostics market was valued at over US$ 6 Bn in 2017 and is expected to grow at a double digit in the forecasted period. The growth of this market can be attributed to the factors such as, growing number of infectious diseases, hospital acquired infections and various other diseases. It is anticipated to grow at a 8.7% CAGR from 2019 to 2030.
New York, NY -- (SBWIRE) -- 04/07/2020 -- Molecular diagnostics is a vital tool for the cost-effective, accurate, rapid, delivery of effective and safe therapy for many diseases. Increasing cases of hospital acquired infections and (add more drivers) have led to the growing need for molecular diagnostic in hospitals facilities. According to Centers for Disease Control (CDC) in 2017, Hospitals Acquired Infections (HAI) accounted for almost 1.7 million cases with 99,000 deaths every year in the U.S.
Some of the major players in the molecular diagnostics market include Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific, Becton, Dickinson and Company, Illumina, QIAGEN N.V., Danaher Corporation, Hologic, F. Hoffmann-La Roche, and Biomerieux SA., among others.
Get Access to Sample Pages @ https://www.marketindustryreports.com/pdf/10
Introduction of quantitative real-time PCR (qPCR) or quantitative polymerase chain reaction (qPCR) is increasingly gaining acceptance owing to the identification of pathogens in clinical microbiology. This tool can be also used to detect of P. aeruginosa easily from sputum samples of patients suffering from Cystic fibrosis, corneal samples, chronic wounds, and positive blood samples.
Technological advancements in the field of molecular diagnostics are expected to drive the market as they allow greater portability, accuracy, and cost-effectiveness. For instance, the introduction of MinION, by Nanopore Technologies offers an affordable and portable sequencer, catering to the users in point-of-care facilities and small peripheral laboratories, which is expected to boost the growth of global molecular diagnostics market.
Increasing Government Grants to Boost the Market
Increasing funding by governments and various organizations for research and clinical studies in the molecular diagnosis space are anticipated to boost the market growth. These initiatives by the government play an important role in the practice of new product development. For instance, Accelerate Diagnostics received a funding of USD 19.45 million by different organizations, including the Oracle Institutional Partners, Schuler Family Foundation, Oracle Partners, & various others, for development and sale of IVD tests and tools. Moreover, in 2015, Merck's venture capital arm funded AdvanDx with almost USD 12 million for R&D of pathogen screening for key HAI.
Get Free Customization @ https://www.marketindustryreports.com/free-customization/10
Table of Contents
Years Considered for the Study
Historical Years – 2016 & 2017
Base Year – 2018
Forecasted Years – 2019 to 2030
Currency Used for the Study
Report Beneficiary List
Data Collection Technique
Market Estimation Methodology
Bottoms Up Approach
Top Down Approach
Data Validation and Triangulation
Market Forecasting Model
Limitations of the Study
Assumptions of the Study
Buy Full Research Report @ https://www.marketindustryreports.com/checkout/10
2nd Floor, Manikchand Ikon,
B-Wing, Dhole Patil Road,
Sangamwadi, Pune 411 001
Phone: +1 347 767 5477 ( US ) + 91 8956 767 535 ( IN ) + 44 131 463 4161 ( UK )